TBCRC 022: Phase II trial of neratinib for patients (Pts) with human epidermal growth factor receptor 2 (HER2+) breast cancer and brain metastases (BCBM).
暂无分享，去创建一个
E. Winer | Minetta C. Liu | N. Ibrahim | R. Gelman | K. Blackwell | A. Wolff | N. Agar | M. Melisko | A. Lowe | S. Puhalla | I. Krop | J. Wefel | R. Connolly | C. Poznak | R. Freedman | P. Niravath | E. Lawler | N. Ryabin | N. Lin